
Glimsayoka 1mg Tablet
Marketer
Sayoka Pharmaceutical (OPC) Pvt Ltd
Salt Composition
Glimepiride (1mg)
Overview Glimsayoka 1mg Tablet
Diabetace 1mg tablets, a sulfonylurea medication, manage type 2 diabetes in adults. By regulating blood glucose, it mitigates severe diabetic complications like vision impairment and kidney failure. Diabetace 1mg may be prescribed alone or in conjunction with other therapies. Administer it immediately before or with your initial daily meal, consistently at the same time for optimal efficacy. Dosage is determined by your physician and may adjust based on your blood sugar readings. Continuous use of Diabetace 1mg is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, risking complications including neuropathy, renal damage, blindness, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as recommended by your healthcare provider. Lifestyle modifications are key to successful diabetes control. Common side effects include hypoglycemia (low blood sugar), nausea, headache, fatigue, and vertigo. Learn to identify hypoglycemia symptoms (sweating, dizziness, tremors, headache) and appropriate countermeasures. Maintain regular mealtimes and carry a fast-acting glucose source (sugary foods, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Weight gain is a potential side effect. Diabetace 1mg is contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any prior heart, thyroid, or hormonal disorders before commencing treatment, as suitability may vary. Pregnant or lactating individuals should seek medical counsel before use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Uses of Glimsayoka 1mg Tablet
Managing type 2 diabetes
Major Benefits of Glimsayoka 1mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimsayoka 1mg Tablet should be administered with a meal.
Common Side effects of Glimsayoka 1mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Dizziness
- Weakness
How to use Glimsayoka 1mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimsayoka 1mg Tablets should be administered with a meal.
How Glimsayoka 1mg Tablet works:
One milligram Glimsayoka tablets are used to treat diabetes. Their mechanism involves stimulating pancreatic insulin secretion, thus reducing blood sugar levels.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimsayoka 1mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Pregnant women may experience adverse effects from Glimsayoka 1mg tablets. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the risks and advantages before prescribing this medication. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimsayoka 1mg Tablet while breastfeeding is potentially hazardous. Available human data indicates possible transfer of the medication into breast milk, posing a risk to the infant. Close observation of the nursing infant's blood sugar levels is recommended when the mother is taking Glimsayoka 1mg Tablet.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glimsayoka 1mg Tablets cautiously, potentially requiring dosage modification. Consult your physician. Glimsayoka 1mg Tablets are contraindicated in individuals with severe kidney disease due to the risk of severe, though potentially reversible, hypoglycemia.
LiverCAUTION
Patients with hepatic impairment should use Glimsayoka 1mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. Glimsayoka 1mg tablets are contraindicated in patients with severe liver disease due to the risk of pronounced hypoglycemia, which may resolve only after an extended period.
What if you forget to take Glimsayoka 1mg Tablet :
Omit the missed Glimsayoka 1mg Tablet dose and continue with your regular dosing schedule.
Facts to Know About Glimsayoka 1mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Advanced Sulfonylurea |
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
